Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Controlled human infection with Bordetella pertussis induces asymptomatic, immunising colonisation.

de Graaf H, Ibrahim M, Hill AR, Gbesemete D, Vaughan AT, Gorringe A, Preston A, Buisman AM, Faust SN, Kester KE, Berbers GAM, Diavatopoulos DA, Read RC.

Clin Infect Dis. 2019 Sep 28. pii: ciz840. doi: 10.1093/cid/ciz840. [Epub ahead of print]

PMID:
31562530
2.

Timeliness of immunisations in preterm infants in the Netherlands.

Rouers EDM, Berbers GAM, van Dongen JAP, Sanders EAM, Bruijning-Verhagen P; PRIEMA study group.

Vaccine. 2019 Sep 16;37(39):5862-5867. doi: 10.1016/j.vaccine.2019.08.006. Epub 2019 Aug 20.

PMID:
31443994
3.

Early prevention of pertussis is key - Author's reply.

Barug D, Pronk I, van Houten M, Versteegh F, Knol M, Berbers G, Sanders E, Rots N.

Lancet Infect Dis. 2019 Jul;19(7):689-690. doi: 10.1016/S1473-3099(19)30315-9. No abstract available.

PMID:
31250812
4.

Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus Proteins.

Schepp RM, de Haan CAM, Wilkins D, Layman H, Graham BS, Esser MT, Berbers GAM.

mSphere. 2019 Apr 24;4(2). pii: e00236-19. doi: 10.1128/mSphere.00236-19.

5.

Persistent circulation of vaccine serotypes and serotype replacement after five years of UK infant immunisation with PCV13.

Kandasamy R, Voysey M, Collins S, Berbers G, Robinson H, Noel I, Hughes H, Ndimah S, Gould K, Fry N, Sheppard C, Ladhani S, Snape MD, Hinds J, Pollard AJ.

J Infect Dis. 2019 Apr 20. pii: jiz178. doi: 10.1093/infdis/jiz178. [Epub ahead of print]

PMID:
31004136
6.

Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.

Barug D, Pronk I, van Houten MA, Versteegh FGA, Knol MJ, van de Kassteele J, Berbers GAM, Sanders EAM, Rots NY.

Lancet Infect Dis. 2019 Apr;19(4):392-401. doi: 10.1016/S1473-3099(18)30717-5. Epub 2019 Mar 27.

PMID:
30938299
7.

Persistence of pneumococcal antibodies after primary immunisation with a polysaccharide-protein conjugate vaccine.

Zimmermann P, Perrett KP, Berbers G, Curtis N.

Arch Dis Child. 2019 Jul;104(7):680-684. doi: 10.1136/archdischild-2018-316254. Epub 2019 Feb 22.

PMID:
30796020
8.

Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015.

Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S, Stefanelli P, van Gent M, Berbers G, Vestrheim D, Greve-Isdahl M, Wehlin L, Ljungman M, Fry NK, Markey K, He Q.

Euro Surveill. 2019 Feb;24(7). doi: 10.2807/1560-7917.ES.2019.24.7.1700832.

9.

Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy - a prospective, observational cohort study from the United Kingdom.

Rice TF, Diavatopoulos DA, Smits GP, van Gageldonk PGM, Berbers GAM, van der Klis FR, Vamvakas G, Donaldson B, Bouqueau M, Holder B, Kampmann B.

Clin Exp Immunol. 2019 Jul;197(1):1-10. doi: 10.1111/cei.13275. Epub 2019 Mar 13.

10.

Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial.

Kandasamy R, Gurung M, Thorson S, Yu LM, Galal U, Voysey M, Kelly S, Wahl B, Berbers G, Finnegan K, Ansari I, Paudel K, Murdoch DR, O'Brien KL, Kelly DF, Goldblatt D, Shrestha S, Pollard AJ.

Lancet Infect Dis. 2019 Feb;19(2):156-164. doi: 10.1016/S1473-3099(18)30568-1. Epub 2019 Jan 8.

PMID:
30635252
11.

Use of saliva to monitor meningococcal vaccine responses: proposing a threshold in saliva as surrogate of protection.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM.

BMC Med Res Methodol. 2019 Jan 5;19(1):1. doi: 10.1186/s12874-018-0650-3.

12.

Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine.

van Westen E, Knol MJ, Wijmenga-Monsuur AJ, Tcherniaeva I, Schouls LM, Sanders EAM, van Els CACM, Berbers GAM, Rots NY.

Vaccines (Basel). 2018 Dec 11;6(4). pii: E82. doi: 10.3390/vaccines6040082.

13.

Effect of Antibiotic-Mediated Microbiome Modulation on Rotavirus Vaccine Immunogenicity: A Human, Randomized-Control Proof-of-Concept Trial.

Harris VC, Haak BW, Handley SA, Jiang B, Velasquez DE, Hykes BL Jr, Droit L, Berbers GAM, Kemper EM, van Leeuwen EMM, Boele van Hensbroek M, Wiersinga WJ.

Cell Host Microbe. 2018 Aug 8;24(2):197-207.e4. doi: 10.1016/j.chom.2018.07.005.

14.

The development of a bead-based multiplex immunoassay for the detection of IgG antibodies to CMV and EBV.

Tcherniaeva I, den Hartog G, Berbers G, van der Klis F.

J Immunol Methods. 2018 Nov;462:1-8. doi: 10.1016/j.jim.2018.07.003. Epub 2018 Jul 26.

15.

Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.

Jonker EFF, van Ravenhorst MB, Berbers GAM, Visser LG.

Vaccine. 2018 Jun 18;36(26):3727-3732. doi: 10.1016/j.vaccine.2018.05.064. Epub 2018 May 16.

PMID:
29778515
16.

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.

van Ravenhorst MB, den Hartog G, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM.

PLoS One. 2018 Apr 19;13(4):e0191261. doi: 10.1371/journal.pone.0191261. eCollection 2018.

17.

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination.

van der Lee S, van Rooijen DM, de Zeeuw-Brouwer ML, Bogaard MJM, van Gageldonk PGM, Marinovic AB, Sanders EAM, Berbers GAM, Buisman AM.

Front Immunol. 2018 Apr 4;9:681. doi: 10.3389/fimmu.2018.00681. eCollection 2018.

18.

Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists.

Bewley MA, Budd RC, Ryan E, Cole J, Collini P, Marshall J, Kolsum U, Beech G, Emes RD, Tcherniaeva I, Berbers GAM, Walmsley SR, Donaldson G, Wedzicha JA, Kilty I, Rumsey W, Sanchez Y, Brightling CE, Donnelly LE, Barnes PJ, Singh D, Whyte MKB, Dockrell DH; COPDMAP.

Am J Respir Crit Care Med. 2018 Sep 15;198(6):739-750. doi: 10.1164/rccm.201705-0903OC.

19.

Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015.

Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S, Stefanelli P, van Gent M, Berbers G, Vestrheim DF, Greve-Isdahl M, Wehlin L, Ljungman M, Fry NK, Markey K, Auranen K, He Q.

J Clin Microbiol. 2018 Apr 25;56(5). pii: e01998-17. doi: 10.1128/JCM.01998-17. Print 2018 May.

20.

Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.

van der Lee S, Hendrikx LH, Sanders EAM, Berbers GAM, Buisman AM.

Front Immunol. 2018 Jan 24;9:51. doi: 10.3389/fimmu.2018.00051. eCollection 2018.

21.

Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults.

van der Heiden M, de Rond LGH, van Zelm MC, Berbers GAM, Boots AMH, Buisman AM.

Front Immunol. 2018 Jan 23;9:46. doi: 10.3389/fimmu.2018.00046. eCollection 2018.

22.

An Explorative Biomarker Study for Vaccine Responsiveness after a Primary Meningococcal Vaccination in Middle-Aged Adults.

van der Heiden M, Berbers GAM, Fuentes S, van Zelm MC, Boots AMH, Buisman AM.

Front Immunol. 2018 Jan 11;8:1962. doi: 10.3389/fimmu.2017.01962. eCollection 2017.

23.

Lower antibody functionality in middle-aged adults compared to adolescents after primary meningococcal vaccination: Role of IgM.

van der Heiden M, van Ravenhorst MB, Bogaard M, Boots AMH, Berbers GAM, Buisman AM.

Exp Gerontol. 2018 May;105:101-108. doi: 10.1016/j.exger.2017.12.014. Epub 2017 Dec 26.

24.

Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.

Boef AGC, van der Klis FRM, Berbers GAM, Buisman AM, Sanders EAM, Kemmeren JM, van der Ende A, de Melker HE, Rots NY, Knol MJ.

Vaccine. 2018 Jan 8;36(3):400-407. doi: 10.1016/j.vaccine.2017.11.070. Epub 2017 Dec 6.

PMID:
29223483
25.

Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.

van der Lee S, Sanders EAM, Berbers GAM, Buisman AM.

Vaccine. 2018 Jan 4;36(2):220-226. doi: 10.1016/j.vaccine.2017.11.066. Epub 2017 Dec 1.

PMID:
29199041
26.

Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection.

van der Lee S, Stoof SP, van Ravenhorst MB, van Gageldonk PGM, van der Maas NAT, Sanders EAM, Buisman AM, Berbers GAM.

Euro Surveill. 2017 Nov;22(47). doi: 10.2807/1560-7917.ES.2017.22.47.17-00011.

27.

Tetanus Toxoid carrier protein induced T-helper cell responses upon vaccination of middle-aged adults.

van der Heiden M, Duizendstra A, Berbers GAM, Boots AMH, Buisman AM.

Vaccine. 2017 Oct 9;35(42):5581-5588. doi: 10.1016/j.vaccine.2017.08.056. Epub 2017 Sep 4.

28.

Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults.

van der Heiden M, Boots AMH, Bonacic Marinovic AA, de Rond LGH, van Maurik M, Tcherniaeva I, Berbers GAM, Buisman AM.

Front Immunol. 2017 Jul 19;8:817. doi: 10.3389/fimmu.2017.00817. eCollection 2017.

29.

Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Knol MJ, Stoof SP, Sanders EAM, Berbers GAM.

Vaccine. 2017 Aug 24;35(36):4745-4752. doi: 10.1016/j.vaccine.2017.06.053. Epub 2017 Jun 28.

PMID:
28668575
30.

Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM.

Vaccine. 2017 Aug 24;35(36):4753-4760. doi: 10.1016/j.vaccine.2017.06.007. Epub 2017 Jun 21.

PMID:
28647167
31.

Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination.

van der Lee S, Kemmeren JM, de Rond LGH, Öztürk K, Westerhof A, de Melker HE, Sanders EAM, Berbers GAM, van der Maas NAT, Rümke HC, Buisman AM.

Pediatr Infect Dis J. 2017 Sep;36(9):e223-e229. doi: 10.1097/INF.0000000000001620.

PMID:
28430750
32.

Dutch national immunization schedule: compliance and associated characteristics for the primary series.

Scheepers ED, van Lier A, Drijfhout IH, Berbers G, van der Maas NAT, de Melker HE, Knol MJ.

Eur J Pediatr. 2017 Jun;176(6):769-778. doi: 10.1007/s00431-017-2904-1. Epub 2017 Apr 20.

PMID:
28429116
33.

Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment.

Groot N, Pileggi G, Sandoval CB, Grein I, Berbers G, Ferriani VPL, Wulffraat N, de Roock S.

Vaccine. 2017 May 15;35(21):2818-2822. doi: 10.1016/j.vaccine.2017.04.015. Epub 2017 Apr 12.

PMID:
28412076
34.

A novel multiplex poliovirus binding inhibition assay applicable for large serosurveillance and vaccine studies, without the use of live poliovirus.

Schepp RM, Berbers GA, Ferreira JA, Reimerink JH, van der Klis FR.

J Virol Methods. 2017 Mar;241:15-23. doi: 10.1016/j.jviromet.2016.12.006. Epub 2016 Dec 14.

35.

Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence.

Stoof SP, van Ravenhorst MB, van Rooijen DM, de Voer RM, van der Klis FRM, Boland GJ, Sanders EAM, Berbers GAM, Teunis PF.

Clin Vaccine Immunol. 2017 Feb 6;24(2). pii: e00429-16. doi: 10.1128/CVI.00429-16. Print 2017 Feb.

36.

Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.

van Ravenhorst MB, Marinovic AB, van der Klis FR, van Rooijen DM, van Maurik M, Stoof SP, Sanders EA, Berbers GA.

Vaccine. 2016 Dec 7;34(50):6309-6315. doi: 10.1016/j.vaccine.2016.10.049. Epub 2016 Nov 4.

PMID:
27817957
37.

Introduction of the 13-valent pneumococcal conjugate vaccine in an isolated pneumococcal vaccine-naïve indigenous population.

Verhagen LM, Rivera-Olivero IA, Hermsen M, Sisco MC, Maes M, Del Nogal B, Bogaert D, Berbers GA, Hermans PW, de Jonge MI, de Waard JH.

Eur Respir J. 2016 Nov;48(5):1492-1496. doi: 10.1183/13993003.00890-2016. Epub 2016 Aug 18. No abstract available.

38.

Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females.

van der Heiden M, van Zelm MC, Bartol SJW, de Rond LGH, Berbers GAM, Boots AMH, Buisman AM.

Sci Rep. 2016 May 31;6:26892. doi: 10.1038/srep26892.

39.

Correction: Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.

Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY.

PLoS One. 2016 May 11;11(5):e0155088. doi: 10.1371/journal.pone.0155088. eCollection 2016.

40.

Stunting correlates with high salivary and serum antibody levels after 13-valent pneumococcal conjugate vaccination of Venezuelan Amerindian children.

Verhagen LM, Hermsen M, Rivera-Olivero I, Sisco MC, Pinelli E, Hermans PW, Berbers GA, de Waard JH, de Jonge MI.

Vaccine. 2016 Apr 29;34(20):2312-20. doi: 10.1016/j.vaccine.2016.03.066. Epub 2016 Mar 29.

PMID:
27036512
41.

Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study.

Swart EM, van Gageldonk PG, de Melker HE, van der Klis FR, Berbers GA, Mollema L.

PLoS One. 2016 Feb 10;11(2):e0148605. doi: 10.1371/journal.pone.0148605. eCollection 2016.

42.

The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections.

van Twillert I, Bonačić Marinović AA, van Gaans-van den Brink JA, Kuipers B, Berbers GA, van der Maas NA, Verheij TJ, Versteegh FG, Teunis PF, van Els CA.

PLoS One. 2016 Feb 5;11(2):e0148507. doi: 10.1371/journal.pone.0148507. eCollection 2016.

43.

Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era.

Prins-van Ginkel AC, Berbers GA, Grundeken LH, Tcherniaeva I, Wittenberns JI, Elberse K, Mollema L, de Melker HE, Knol MJ.

PLoS One. 2016 Jan 21;11(1):e0147437. doi: 10.1371/journal.pone.0147437. eCollection 2016.

44.

Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.

Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY.

PLoS One. 2015 Dec 10;10(12):e0144739. doi: 10.1371/journal.pone.0144739. eCollection 2015. Erratum in: PLoS One. 2016;11(5):e0155088.

45.

Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age?

Stoof SP, Buisman AM, van Rooijen DM, Boonacker R, van der Klis FR, Sanders EA, Berbers GA.

PLoS One. 2015 Oct 12;10(10):e0138665. doi: 10.1371/journal.pone.0138665. eCollection 2015.

46.

Response on Pneumococcal Vaccine in Preterm Infants After Neutral and Acidic Oligosaccharides Supplementation.

van den Berg JP, Westerbeek EA, van der Klis FR, Sanders EA, Berbers GA, van Elburg RM.

Pediatr Infect Dis J. 2015 Sep;34(9):976-82. doi: 10.1097/INF.0000000000000766.

PMID:
26153784
47.

Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.

Stoof SP, Rodenburg GD, Knol MJ, Rümke LW, Bovenkerk S, Berbers GA, Spanjaard L, van der Ende A, Sanders EA.

Clin Infect Dis. 2015 Oct 15;61(8):1281-92. doi: 10.1093/cid/civ506. Epub 2015 Jun 29.

PMID:
26123933
48.

Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool.

Stoof SP, van der Klis FR, van Rooijen DM, Bogaert D, Trzciński K, Sanders EA, Berbers GA.

Vaccine. 2015 Jul 31;33(32):3933-9. doi: 10.1016/j.vaccine.2015.06.055. Epub 2015 Jun 19.

PMID:
26100925
49.

Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.

van Westen E, Wijmenga-Monsuur AJ, van Dijken HH, van Gaans-van den Brink JA, Kuipers B, Knol MJ, Berbers GA, Sanders EA, Rots NY, van Els CA.

Clin Infect Dis. 2015 Aug 1;61(3):342-9. doi: 10.1093/cid/civ274. Epub 2015 Apr 1.

50.

Identification of pertussis-specific effector memory T cells in preschool children.

de Rond L, Schure RM, Öztürk K, Berbers G, Sanders E, van Twillert I, Carollo M, Mascart F, Ausiello CM, van Els CA, Smits K, Buisman AM.

Clin Vaccine Immunol. 2015 May;22(5):561-9. doi: 10.1128/CVI.00695-14. Epub 2015 Mar 18.

Supplemental Content

Loading ...
Support Center